HomeHome E-mail this pageE-mail this page Print this pagePrint this page
The Mark of Individualized Medicine monogram biosciences
About Us HIV Products Oncology Products Pharma Partnerships Investors/Media Careers
Stock Quote

SEC Filings

News & Press Releases

Key Ratios

Corporate Governance

Events & Webcasts

FAQ
Register for Updates
Investors/Media
Type size: + -
Media

Monogram's media center is designed to provide you with easy access to news about the company and its products and to electronic documents typically found in an information kit. If you don't find what you are looking for or need more information, please contact us.

 View archived press releases.

 Recent Press Releases
May 01, 2008 HER1 and HER3 VeraTag Assays are Now Available for Use in Development and Clinical Evaluation of Cancer Therapeutics
 
May 01, 2008 Monogram Announces 2008 First Quarter Financial Results
 
Apr 21, 2008 Monogram Biosciences Announces First Quarter 2008 Financial Results Conference Call
 
Apr 14, 2008 Monogram Biosciences to Present at the JMP Securities Seventh Annual Research Conference
 
Apr 08, 2008 New York Medicaid Program Establishes Coverage for Trofile(TM)
 
Apr 01, 2008 Monogram Biosciences Provides Progenics Pharmaceuticals with HIV Assays for Use in Clinical Trials
 

 Investor and Media Contacts

For Investors:
Alfred Merriweather
650-635-1100
ir@monogrambio.com

For Media:
Jeremiah Hall or Kas Das
Feinstein Kean Healthcare
(415) 677-2720
Jeremiah.Hall@fkhealth.com or
Kaustuva.Das@fkhealth.com


Shareholder Tools
Briefcase Briefcase
Investor Kit Investor Kit
Email Alerts Alerts
Download Center Download Library
Glossary Glossary
RSS News Feeds
  


Virtual IR Kit
Click here to get Corporate Fact Sheet, Backgrounders, Annual Reports.

TScientific Publications, Posters and Articles
Click here to view recent HIV scientific publications.

Click here to view recent oncology scientific publications.
Contact Us  |  Site Map  |  Privacy Policy  |  Health Disclaimer  |  HIPAA Practice  |  Home